Lountzis Asset Management’s AbbVie ABBV Stock Holding History

Lountzis Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$764K	Hold	3,511	–	–	0.28%	25
2025 Q4	$802K	Buy	3,511 +211	+6%	+$48.1K	0.28%	25
2025 Q3	$764K	Hold	3,300	–	–	0.25%	27
2025 Q2	$613K	Hold	3,300	–	–	0.22%	35
2025 Q1	$640K	Hold	3,300	–	–	0.24%	32
2024 Q4	$586K	Hold	3,300	–	–	0.25%	31
2024 Q3	$652K	Hold	3,300	–	–	0.27%	30
2024 Q2	$566K	Hold	3,300	–	–	0.26%	29
2024 Q1	$601K	Hold	3,300	–	–	0.28%	27
2023 Q4	$511K	Hold	3,300	–	–	0.28%	28
2023 Q3	$492K	Hold	3,300	–	–	0.27%	27
2023 Q2	$502K	Hold	3,300	–	–	0.28%	27
2023 Q1	$526K	Hold	3,300	–	–	0.31%	27
2022 Q4	$483K	Hold	3,300	–	–	0.29%	24
2022 Q3	$442K	Hold	3,300	–	–	0.3%	25
2022 Q2	$505K	Hold	3,300	–	–	0.34%	24
2022 Q1	$535K	Hold	3,300	–	–	0.3%	24
2021 Q4	$447K	Hold	3,300	–	–	0.26%	24
2021 Q3	$356K	Hold	3,300	–	–	0.22%	25
2021 Q2	$371K	Hold	3,300	–	–	0.23%	27
2021 Q1	$357K	Hold	3,300	–	–	0.24%	25
2020 Q4	$354K	Hold	3,300	–	–	0.26%	22
2020 Q3	$289K	Hold	3,300	–	–	0.25%	23
2020 Q2	$324K	Buy	+3,300	New	+$291K	0.31%	22

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lountzis Asset Management's ABBV Position: Q1 2026 in Review

Lountzis Asset Management held its AbbVie (ABBV) position steady in Q1 2026 at 3,511 shares worth $764K. The position accounts for 0.28% of the portfolio, ranked #25.

Lountzis Asset Management first reported a position in ABBV in Q2 2020 and has held it in 24 quarters since. The position peaked at $802K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Lountzis Asset Management held 3,511 shares of AbbVie worth $764K as of Q1 2026.
Lountzis Asset Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.28% of Lountzis Asset Management's portfolio in Q1 2026, its #25 holding.
Lountzis Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 24 quarters since.
Lountzis Asset Management's AbbVie position peaked at $802K in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Lountzis Asset Management's 13F filing for Q1 2026, filed 7 May 2026.